After COVID, Surgery Risks Remain Higher for More Than a Year
THURSDAY, Dec. 15, 2022 (HealthDay News) — Doctors and patients should consider COVID-19 history when planning surgery, according to a new study.For patients who’ve had a COVID-19 diagnosis, researchers found significant postoperative problems dimini…
Learn MorePandemic’s Two-Year Global Death Toll May Be Close to 15 Million
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — Almost 15 million people likely died as a result of the COVID-19 pandemic in 2020 and 2021, nearly three times more than previously reported, a new World Health Organization study estimates.The researchers …
Learn MoreLas autoridades de salud de EE. UU. piden usar máscaras bajo techo en las ciudades: la ‘triplemia’ arrasa
LUNES, 12 de diciembre de 2022 (HealthDay News) — Mientras tres virus respiratorios altamente contagiosos se propagan por todo Estados Unidos, presionando a los hospitales y provocando escasez de medicamentos, las autoridades de salud de algunas gran…
Learn MorePost-COVID-19 Syndrome Triples Use of Further Health Care Services
TUESDAY, Dec. 13, 2022 (HealthDay News) — People with long COVID are more likely to use health care services following acute infection, according to a study published online Nov. 30 in PLOS Global Public Health.Maciej Debski, M.D., Ph.D., from the Un…
Learn MoreU.S. Health Officials Urge Indoor Masking in Major Cities as ‘Tripledemic’ Rages
MONDAY, Dec. 12, 2022 (HealthDay News) – As three highly contagious respiratory viruses spread across the United States, straining hospitals and triggering drug shortages, health officials in some major cities and states are calling for a return to in…
Learn MoreJYNNEOS Vaccination Provides Protection Against Mpox
THURSDAY, Dec. 8, 2022 (HealthDay News) — Among men aged 18 to 49 years who are eligible for the JYNNEOS vaccine, mpox incidence is considerably higher among unvaccinated persons versus those who received one or two vaccine doses, according to resea…
Learn MoreMost Common Adverse Events With JYNNEOS Are Nonserious
THURSDAY, Dec. 8, 2022 (HealthDay News) — The JYNNEOS vaccine, which is recommended for persons exposed to or at high risk for exposure to mpox virus, seems safe, with the most common adverse health events reported as nonserious, according to resear…
Learn MorePaxlovid pronto no será gratuito para los estadounidenses
MIÉRCOLES, 7 de diciembre de 2022 (HealthDay News) — El antiviral Paxlovid ha evitado que las personas enfermen de gravedad y mueran por la COVID-19 desde que salió, sin ningún costo para ellas.Pero a mediados del próximo año, el gobierno de EE. UU. …
Learn MorePaxlovid Soon Won’t Be Free for Americans
WEDNESDAY, Dec. 7, 2022 (HealthDay News) — The antiviral Paxlovid has kept people from getting really sick and dying from COVID-19 since it became available — at no cost to them. But by the middle of next year, the U.S. government will stop subsidiz…
Learn MoreCooler Noses May Be Key to Winter’s Spike in Colds
TUESDAY, Dec. 6, 2022 (HealthDay News) — Researchers may have sniffed out why colds are more likely in wintertime: The answer may lie within the nose.A previously unidentified immune response inside the nose is responsible for fighting off the viruse…
Learn More